Cargando…
Latex immunotherapy: evidence of effectiveness
INTRODUCTION: The only etiological and decisive therapy, able to influence the natural history of latex allergy is the specific desensitization. AIM: To verify the clinical efficacy and immunological changes determined by latex sublingual immunotherapy in allergic patients who underwent this treatme...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949543/ https://www.ncbi.nlm.nih.gov/pubmed/29760613 http://dx.doi.org/10.5114/ada.2018.75235 |
_version_ | 1783322735543320576 |
---|---|
author | Nucera, Eleonora Mezzacappa, Simona Buonomo, Alessandro Centrone, Michele Rizzi, Angela Manicone, Paolo Francesco Patriarca, Giampiero Aruanno, Arianna Schiavino, Domenico |
author_facet | Nucera, Eleonora Mezzacappa, Simona Buonomo, Alessandro Centrone, Michele Rizzi, Angela Manicone, Paolo Francesco Patriarca, Giampiero Aruanno, Arianna Schiavino, Domenico |
author_sort | Nucera, Eleonora |
collection | PubMed |
description | INTRODUCTION: The only etiological and decisive therapy, able to influence the natural history of latex allergy is the specific desensitization. AIM: To verify the clinical efficacy and immunological changes determined by latex sublingual immunotherapy in allergic patients who underwent this treatment for at least 3 years. MATERIAL AND METHODS: We enrolled 76 patients (16 males and 60 females, mean age 34 years old) with evidence of a natural rubber latex allergy. To assess the effectiveness of the immunotherapy we performed a latex skin prick test, specific IgE and IgG4 and challenge tests before and after at least 3 years of desensitization. RESULTS: We observed a reduction in the mean diameter of the wheal area at the skin prick test and a decrease in latex specific IgE while no significant changes of latex IgG4 values were found. Moreover a reduction of symptoms and scores at the provocation tests were remarked. CONCLUSIONS: Although the primary prevention (which still remains the gold standard treatment for patients suffering from the latex allergy) sublingual immunotherapy can be offered with efficacy in addition to symptomatic treatment to selected patients. |
format | Online Article Text |
id | pubmed-5949543 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-59495432018-05-14 Latex immunotherapy: evidence of effectiveness Nucera, Eleonora Mezzacappa, Simona Buonomo, Alessandro Centrone, Michele Rizzi, Angela Manicone, Paolo Francesco Patriarca, Giampiero Aruanno, Arianna Schiavino, Domenico Postepy Dermatol Alergol Original Paper INTRODUCTION: The only etiological and decisive therapy, able to influence the natural history of latex allergy is the specific desensitization. AIM: To verify the clinical efficacy and immunological changes determined by latex sublingual immunotherapy in allergic patients who underwent this treatment for at least 3 years. MATERIAL AND METHODS: We enrolled 76 patients (16 males and 60 females, mean age 34 years old) with evidence of a natural rubber latex allergy. To assess the effectiveness of the immunotherapy we performed a latex skin prick test, specific IgE and IgG4 and challenge tests before and after at least 3 years of desensitization. RESULTS: We observed a reduction in the mean diameter of the wheal area at the skin prick test and a decrease in latex specific IgE while no significant changes of latex IgG4 values were found. Moreover a reduction of symptoms and scores at the provocation tests were remarked. CONCLUSIONS: Although the primary prevention (which still remains the gold standard treatment for patients suffering from the latex allergy) sublingual immunotherapy can be offered with efficacy in addition to symptomatic treatment to selected patients. Termedia Publishing House 2018-04-24 2018-04 /pmc/articles/PMC5949543/ /pubmed/29760613 http://dx.doi.org/10.5114/ada.2018.75235 Text en Copyright: © 2018 Termedia Sp. z o. o. http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
spellingShingle | Original Paper Nucera, Eleonora Mezzacappa, Simona Buonomo, Alessandro Centrone, Michele Rizzi, Angela Manicone, Paolo Francesco Patriarca, Giampiero Aruanno, Arianna Schiavino, Domenico Latex immunotherapy: evidence of effectiveness |
title | Latex immunotherapy: evidence of effectiveness |
title_full | Latex immunotherapy: evidence of effectiveness |
title_fullStr | Latex immunotherapy: evidence of effectiveness |
title_full_unstemmed | Latex immunotherapy: evidence of effectiveness |
title_short | Latex immunotherapy: evidence of effectiveness |
title_sort | latex immunotherapy: evidence of effectiveness |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949543/ https://www.ncbi.nlm.nih.gov/pubmed/29760613 http://dx.doi.org/10.5114/ada.2018.75235 |
work_keys_str_mv | AT nuceraeleonora lateximmunotherapyevidenceofeffectiveness AT mezzacappasimona lateximmunotherapyevidenceofeffectiveness AT buonomoalessandro lateximmunotherapyevidenceofeffectiveness AT centronemichele lateximmunotherapyevidenceofeffectiveness AT rizziangela lateximmunotherapyevidenceofeffectiveness AT maniconepaolofrancesco lateximmunotherapyevidenceofeffectiveness AT patriarcagiampiero lateximmunotherapyevidenceofeffectiveness AT aruannoarianna lateximmunotherapyevidenceofeffectiveness AT schiavinodomenico lateximmunotherapyevidenceofeffectiveness |